Erythropoietic Agents has 1 known drug interaction based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Lenalidomide. Patients taking Erythropoietic Agents should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Major
- 1
Major (1)
- Erythropoietic Agents + Lenalidomide— Concomitant use with lenalidomide may increase the risk of thrombosis. Should be used with caution after benefit-risk as…